Alan B. Glassberg
Corporate Officer/Principal bij The University of California, San Francisco
Profiel
Alan B.
Glassberg is currently a Principal at The University of California, San Francisco.
He was previously a Director at Biogen, Inc. from 1997 to 2009 and a Director at Biogen Idec New Ventures, Inc. from 1997 to 2008.
He also held positions as a Director at IDEC Pharmaceuticals Corp., a Director at Aravive Biologics, Inc., and a Chief Medical Officer at Poniard Pharmaceuticals, Inc. Additionally, he was a Member at Bay City Capital LLC.
Glassberg holds a doctorate from the Medical University of South Carolina and an undergraduate degree from the College of Charleston.
Actieve functies van Alan B. Glassberg
| Bedrijven | Functie | Begin |
|---|---|---|
| The University of California, San Francisco | Corporate Officer/Principal | 01-01-1970 |
Eerdere bekende functies van Alan B. Glassberg
| Bedrijven | Functie | Einde |
|---|---|---|
| BIOGEN INC. | Director/Board Member | 01-06-2009 |
Biogen Idec New Ventures, Inc.
 Biogen Idec New Ventures, Inc. Investment ManagersFinance Founded in 2004, Biogen Idec New Ventures is the corporate venture group of Biogen Idec, Inc. In 2003, Biogen and IDEC Pharmaceuticals merged to create Biogen Idec, Inc. (NASDAQ: BIIB) | Director/Board Member | 31-12-2008 |
| PONIARD PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 15-03-2007 |
Aravive Biologics, Inc.
 Aravive Biologics, Inc. Pharmaceuticals: MajorHealth Technology Aravive Biologics, Inc. develops novel targeted therapeutics in oncology. The company was founded by Amato Giaccia and Albert Koong and is headquartered in Houston, TX. | Director/Board Member | - |
Bay City Capital LLC
 Bay City Capital LLC Investment ManagersFinance Bay City Capital LLC (Bay City Capital) is a venture capital firm founded in 1997 by Fred Craves, John Diekman, and Thomas Pritzker. The firm is headquartered in California, United States. | Corporate Officer/Principal | - |
Opleiding van Alan B. Glassberg
| Medical University of South Carolina | Doctorate Degree |
| College of Charleston | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| PONIARD PHARMACEUTICALS, INC. | Health Technology |
| BIOGEN INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
IDEC Pharmaceuticals Corp.
 IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | Health Technology |
Bay City Capital LLC
Bay City Capital LLC Investment ManagersFinance Bay City Capital LLC (Bay City Capital) is a venture capital firm founded in 1997 by Fred Craves, John Diekman, and Thomas Pritzker. The firm is headquartered in California, United States. | Finance |
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Founded in 2004, Biogen Idec New Ventures is the corporate venture group of Biogen Idec, Inc. In 2003, Biogen and IDEC Pharmaceuticals merged to create Biogen Idec, Inc. (NASDAQ: BIIB) | Finance |
Aravive Biologics, Inc.
Aravive Biologics, Inc. Pharmaceuticals: MajorHealth Technology Aravive Biologics, Inc. develops novel targeted therapeutics in oncology. The company was founded by Amato Giaccia and Albert Koong and is headquartered in Houston, TX. | Health Technology |
